Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Acta paediatrica

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1651-2227.2001.tb00306.xPMID 11332169
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs.

  1998cited by this paper
• Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.

  1998cited by this paper
• Birth outcomes in pregnant women taking fluoxetine.

  1997influential reference
• Paroxetine withdrawal syndrome in a neonate

  1997cited by this paper
• Potential fluoxetine chloride (Prozac) toxicity in a newborn.

  1997cited by this paper
• Birth outcomes in pregnant women taking fluoxetine.

  1996cited by this paper
• Suspected congenital sertraline dependence

  1995cited by this paper
• Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)

  1993cited by this paper
• Fluoxetine hydrochloride (Prozac) toxicity in a neonate.

  1993cited by this paper
• Neonatal Withdrawal Symptoms After Chronic Maternal Ingestion of Caffeine

  1988cited by this paper
• Neonatal convulsions caused by withdrawal from maternal clomipramine.

  1982cited by this paper
• Adverse reactions to drug withdrawal

  1977cited by this paper
• Withdrawal symptoms in neonates associated with maternal antidepressant therapy.

  1973cited by this paper
• Emanuel Miller. M.A. Cantab., F.R.C.P., D.P.M.

  1970cited by this paper

• Panic disorder during pregnancy and the first three years after delivery: a systematic review

  2025cites this paper
• A Review of Neonatal Selective Serotonin Reuptake Inhibitor Withdrawal Syndrome.

  2025cites this paper
• Mimickers of Hypoxic Ischemic Encephalopathy.

  2025cites this paper
• Maternal treatment with a selective delta-opioid receptor agonist during gestation has a sex-specific pro-cognitive action in offspring: mechanisms involved.

  2024cites this paper
• Screening prenatal depression to assess childbirth and neonatal complications: a cohort study

  2023cites this paper
• Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome

  2022influential citation
• Global research production in neonatal abstinence syndrome: A bibliometric analysis

  2022cites this paper
• Physiologic dysregulation in newborns with prenatal opioid exposure: Cardiac, respiratory and movement activity.

  2022cites this paper
• Effect of Selected Antidepressants on Placental Homeostasis of Serotonin: Maternal and Fetal Perspectives

  2021cites this paper
• Serotonin Toxicity Versus Withdrawal: Clonidine One Size Fits All?

  2021cites this paper
• Serotonin and development

  2020cites this paper
• The Developmental Role of Serotonin: A Comparison of Short- and Long-term Blockade of the Serotonin Transporter on Behavioural Outcomes in Adulthood

  2020influential citation
• Serotonin-estrogen interactions: What can we learn from pregnancy?

  2019cites this paper
• Pharmacokinetic considerations for current state-of-the-art antidepressants

  2019cites this paper
• Drug Monitoring in Breast Milk: Novel Insights on Pharmacokinetics and Infant Exposure Estimates

  2018cites this paper
• Passive Addiction and Teratogenic Effects

  2018cites this paper
• Predicting Escitalopram Exposure to Breastfeeding Infants: Integrating Analytical and In Silico Techniques

  2018cites this paper
• Neonatal abstinence syndrome due to prenatally citalopram exposure: A case report.

  2017cites this paper
• Quantitative prediction of fetal plasma concentration of fluvoxamine during dosage-tapering to the mother.

  2017cites this paper
• University of Groningen Pharmacological aspects of neonatal antidepressant withdrawal

  2017influential citation
• The effects of maternal antidepressant use on offspring behaviour and brain development: Implications for risk of neurodevelopmental disorders.

  2017cites this paper
• Relationship Between Methadone, Selective Serotonin Reuptake Inhibitors, and Neonatal Abstinence Syndrome.

  2016cites this paper
• Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects

  2016cites this paper
• A patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial

  2016cites this paper
• Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.

  2016cites this paper
• S3-Leitlinie Angststörungen

  2015cites this paper
• Perinatal vs Genetic Programming of Serotonin States Associated with Anxiety

  2015cites this paper
• The use of antidepressants in pregnancy: focus on maternal risks.

  2015cites this paper
• Prenatal SSRI exposure: Effects on later child development

  2015cites this paper
• Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation

  2015cites this paper
• Selective Serotonin Reuptake Inhibitor Use during Pregnancy and the Risk of Autism Spectrum Disorders: A Review

  2015cites this paper
• Médicaments et grossesse : aspects néonatals

  2014cites this paper
• Depresión perinatal: Detección y tratamiento

  2014cites this paper
• Exposure to antidepressants during pregnancy--prevalences and outcomes.

  2014cites this paper
• The use of antidepressant medication in pregnancy.

  2014cites this paper
• Child Neuropsychology: A Journal on Normal and Abnormal Development in Childhood and Adolescence

  2014cites this paper
• Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders

  2014cites this paper
• Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation.

  2014cites this paper
• Transcranial direct current stimulation (tDCS) for treatment of major depression during pregnancy: study protocol for a pilot randomized controlled trial

  2014cites this paper
• Drugs in Pregnancy: Neonatal Aspects

  2014cites this paper
• SSRI use during pregnancy and risk of stillbirth and neonatal mortality.

  2013cites this paper
• Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.

  2013cites this paper
• Special Issues in Managing Migraine in Women: AReview Article

  2013cites this paper
• Pregnancy in Term and Preterm Neonates Effects of Selective Serotonin Reuptake Inhibitors and Venlafaxine During

  2013cites this paper
• DMD052332 2124..2132

  2013cites this paper
• Serotonin Reuptake Inhibitor Medication Exposure Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective

  2013cites this paper
• Neonatal drug withdrawal.

  2013cites this paper
• Characterization of Transplacental Transfer of Paroxetine in Perfused Human Placenta: Development of a Pharmacokinetic Model to Evaluate Tapered Dosing

  2013cites this paper
• Modelling early life exposure to antidepressants in rats: Developmental, behavioural and neurochemical aspects

  2013cites this paper
• Review of calls to an Australian teratogen information service regarding psychotropic medications over a 12‐year period

  2013cites this paper
• Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.

  2012cites this paper
• Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat.

  2012cites this paper
• Neonatal Drug Withdrawal

  2012cites this paper
• Quality assessment of clinical practice guidelines for the prescription of antidepressant drugs during pregnancy.

  2012cites this paper
• CLINICAL REPORT Neonatal Drug Withdrawal

  2012cites this paper
• The baby of a substance-abusing mother

  2012cites this paper
• Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.

  2011cites this paper
• Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons.

  2011cites this paper
• Original Article Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons

  2011cites this paper
• Quality assessment of observational studies in psychiatry: an example from perinatal psychiatric research

  2011cites this paper
• Controversies surrounding pediatric psychopharmacology.

  2011cites this paper
• Antidepressant Drugs and Breastfeeding: A Review of the Literature

  2011cites this paper
• Teratology and Developmental Pharmacology: Why Should Paediatricians Care?

  2011cites this paper
• Gebelikte Psikotrop İlaç Kullanımı: Bir Güncelleme

  2011cites this paper
• Behavioral and Developmental Changes in Rats with Prenatal Exposure of Mirtazapine

  2010cites this paper
• Best Practice & Research, Clinical Obstetrics & Gynaecology

  2010cites this paper
• Neonatal Growth Outcomes at Birth and one Month Postpartum Following In Utero Exposure to Antidepressant Medication

  2010cites this paper
• Depresión en el embarazo y el puerperio Depression in pregnancy and the puerperium

  2010cites this paper
• On Categorizing Gestational, Birth, and Neonatal Complications Following Late Pregnancy Exposure to Antidepressants: The Prenatal Antidepressant Exposure Syndrome

  2010cites this paper
• Migraine therapy during pregnancy and lactation

  2010cites this paper
• Prenatal exposure to serotonin reuptake inhibitors: a case report

  2010cites this paper
• Neonatal abstinence syndrome (NAS)

  2009cites this paper
• Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.

  2009cites this paper
• Serotonin Discontinuation Syndrome Following in Utero Exposure to Antidepressant Medication: Prospective Controlled Study

  2009cites this paper
• Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy.

  2009cites this paper
• Use of SSRIs in pregnancy: neonatal implications.

  2009cites this paper
• Effect of Exposure to Selective Serotonin Reuptake Inhibitors In Utero on Fetal Growth: Potential Role for the IGF-I and HPA Axes

  2009cites this paper
• Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

  2009cites this paper
• Antidepressants during pregnancy, risks for mother and child

  2009cites this paper
• Psychiatric Disorders in Pregnancy

  2009cites this paper
• Neonatal abstinence syndrome

  2008cites this paper
• Depression, antidepressant medication, and functioning outcomes among pregnant women

  2008cites this paper
• In Utero Exposure to Selective Serotonin Reuptake Inhibitors: Evidence for Poor Neonatal Adaptation

  2008cites this paper
• Paroxetine

  2008cites this paper
• Pharmacological Aspects of Neonatal Antidepressant Withdrawal

  2008influential citation
• Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications

  2008cites this paper
• Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.

  2008cites this paper
• Prolonged neonatal complications after in utero exposure to fluoxetine

  2008cites this paper
• Neurofunctional effects in rats prenatally exposed to fluoxetine.

  2008cites this paper
• Psychotropic medication during pregnancy and lactation

  2007cites this paper
• Serotonin Reuptake Inhibitor-Induced Perinatal Complications

  2007cites this paper
• Depression after Delivery: Risk Factors, Diagnostic and Therapeutic Considerations

  2007cites this paper
• Toxicologic Issues in the Neonate

  2007cites this paper
• Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior.

  2007cites this paper
• Gevolgen ssri-gebruik zwangeren bij de pasgeborene in de eerste 48 uur post partum

  2007cites this paper
• New generation of antidepressants in pregnant women

  2007cites this paper
• Current Dilemmas in Treating Depressed Pregnant Patients

  2007cites this paper
• Effects of Selective Serotonin Reuptake Inhibitors and Venlafaxine During Pregnancy in Term and Preterm Neonates

  2007cites this paper
• An open trial of Omega-3 fatty acids for depression in pregnancy*

  2006cites this paper
• Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.

  2006cites this paper